Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/18/25 18:22 | 6/17/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Kintz Samuel | CO | DO | P,CEO | 5 | S.m | -743 | 19.80 | 0 | -38 | 985 | I | |||||||||||||||
6/17/25 16:24 | 6/13/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Hohl Benjamin | CO | O | CFO | 5 | S.d | -273 | 19.84 | 0 | -14 | 23 | D | |||||||||||||||
6/11/25 18:25 | 6/9/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Patel Anish | CO | O | COO | 3 | S | -378 | 18.92 | 0 | -20 | 317 | I | |||||||||||||||
6/5/25 16:55 | 6/3/25 | ELVN | Health | Drug | Pharmaceutical Preparations | Lyssikatos Joseph P | CO | O | CHIEF SC | 4 | S.m | -463 | 18.50 | 0 | -25 | 998 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |